Results 111 to 120 of about 269,490 (301)

Insulin antibodies in diabetic children before treatment: A marker for islet B-cell destruction?

open access: yes, 1988
peer reviewedInsulin antibodies were measured in the sera of 28 newly diagnosed diabetic children (age 8.0 ± 4.0 (±SD) years) prior to insulin therapy and after 3, 6, 9, and 12 months.
Den Boer, N. C.   +9 more
core   +1 more source

Stable Protein‐Based G‐Quadruplex‐Derived Supramolecular Bioinks as Tunable ECM‐Mimetic Constructs Assembled by Combining Non‐Covalent and Covalent Strategies

open access: yesAdvanced Materials, EarlyView.
Harnessing the synergistic interplay of supramolecular self‐assembly, under macromolecular crowding conditions, and enzymatic‐mediated covalent crosslinking toward a stable protein‐based G‐quadruplex‐derived supramolecular bioink. This bioinspired strategy enables the biofabrication of complex and tunable ECM‐mimetic constructs, providing a platform ...
Vera Sousa   +6 more
wiley   +1 more source

Anti-insulin antibodies in dogs with naturally occurring diabetes mellitus

open access: yes, 2003
The presence of anti-insulin antibodies was determined by ELISA in serum samples from 30 diabetic dogs receiving bovine insulin therapy and 30 normoglycaemic dogs.
Lucy J. Davison   +16 more
core   +1 more source

Turning Unpredictable Biomolecule Adsorption to Controlled Corona Formation: Focus on Carbon Nanomaterials

open access: yesAdvanced Materials, EarlyView.
Controlling the protein corona formation onto carbon nanomaterials (CNMs) enhances their functionalities as platforms for cancer theranostics. Here, we reviewed the effects of the intrinsic and acquired properties of CNMs on protein corona formation, the consequent biological and toxicological outcomes, and the strategies to reshape corona formation ...
Yajuan Zou   +5 more
wiley   +1 more source

Exogenous Insulin Antibody Syndrome in Patients with Type 2 Diabetes

open access: yesDiabetes, Metabolic Syndrome and Obesity, 2023
Chen-Yu Han, Xiao-Mei Ye, Jia-Ping Lu, Hai-Ying Jin, Wei-Wei Xu, Ping Wang, Min Zhang Department of Endocrinology, Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University, Shanghai, 201700, People’s Republic of ChinaCorrespondence: Min Zhang ...
Han CY   +6 more
doaj  

Mycophenolate Mofetil and Plasmapheresis: A Treatment Option for Severe Insulin Resistance caused by Insulin Antibodies. [PDF]

open access: yesAACE Clin Case Rep, 2021
Brooks D   +5 more
europepmc   +1 more source

ANTI-INSULIN RECEPTOR ANTIBODY AND INSULIN RESISTANCE

open access: yesFolia Endocrinologica Japonica, 1992
Type B insulin resistance syndrome is characterized by the presence of a circulating anti-insulin receptor antibody which inhibits insulin action. The syndrome is usually associated with autoimmune diseases, acanthosis nigricans and hyperinsulinemia. The antibody causes insulin resistance by inhibiting insulin binding to insulin receptors, decreasing ...
openaire   +3 more sources

Antiphosphotyrosine antibodies modulate insulin receptor kinase activity and insulin action.

open access: yes, 1989
International audienceInsulin elicits the autophosphorylation of the beta-subunit of its receptor on tyrosine residues: this effect appears to be the earliest post-binding event involved in insulin action.
Ballotti, R   +3 more
core  

Home - About - Disclaimer - Privacy